Previous close | 51.29 |
Open | 51.86 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 51.66 - 52.21 |
52-week range | 50.43 - 75.60 |
Volume | |
Avg. volume | 3 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 31 July 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights CVS Health to hold its Annual General Meeting on 16th of May Salary of US$1.50m is part of CEO Karen...
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
A recent CVS Health® (NYSE: CVS)/Morning Consult survey found that a majority of adults have significant concerns about their mental health and rates across the country continue to rise.